missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18458041

CXCL11/I-TAC Antibody (MM0210-9N26), FITC, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-12219F

Product Code. 18458041

This item has been discontinued and is no longer available. View the product for possible alternatives or contact our Technical Support team on 056 260 260 for assistance.
 View alternative products »

This item is not returnable. View return policy

Description

Description

CXCL11/I-TAC Monoclonal antibody specifically detects CXCL11/I-TAC in Human samples. It is validated for Immunohistochemistry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CXCL11/I-TAC
Monoclonal
FITC
PBS
Mouse
Protein G purified
RUO
Primary
Human, Mouse
Purified
Immunohistochemistry, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin)
MM0210-9N26
Immunohistochemistry
Beta-R1, b-R1, chemokine (C-X-C motif) ligand 11, H174IP9, Interferon gamma-inducible protein 9, Interferon-inducible T-cell alpha chemoattractant, IP-9member 11, ITAC, I-TACMGC102770, small inducible cytokine subfamily B (Cys-X-Cys), member 9B, Small-inducible cytokine B11
Human recombinant CXCL11/I-TAC
0.1 mL
Biologically Active Proteins, Chemokines and Cytokines, Cytokine Research
6373
Store at 4C in the dark.
IgG2
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.